More than 58 million adults in the United States have arthritis, often leading to chronic pain, reduced mobility and difficulty performing daily tasks.
Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...